Clinical, biological, and biochemical effect of pyrazofurin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000577:Amides; D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D051379:Mice; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D009963:Orotic Acid / Q000378:metabolism; D011720:Pyrazoles; D011742:Pyrimidine Nucleotides / Q000378:metabolism; D012263:Ribonucleosides / Q000378:metabolism / Q000494:pharmacology*; D012266:Ribose; D014529:Uridine / Q000494:pharmacology
D000577:Amides; D011720:Pyrazoles; D011742:Pyrimidine Nucleotides; D012263:Ribonucleosides; C002997:pyrazofurin; D009963:Orotic Acid; D012266:Ribose; D014529:Uridine